Modified Exigent Features Block in JAN Net for Analysing SPECT Scan Images to Diagnose Early-Stage Parkinson's
S Jothi1, S Anita2, S Sivakumar3
1Department of Computer Science, Jayaraj Annapackiam College for Women, M. K. University, Madurai, Tamilnadu, India.
Current Medical Imaging
|June 7, 2023
Summary
This study introduces JAN Net, a novel Convolutional Neural Network (CNN), for accurately identifying Parkinson's disease (PD) using dopamine transporter (DaT) SPECT images. The JAN Net achieves 100% accuracy, aiding neurologists in protecting neurons.
Area of Science:
- Neuroscience
- Medical Imaging
- Artificial Intelligence
Background:
- Dopamine transporter (DaT) quantification in the midbrain serves as a biomarker for Parkinson's disease (PD).
- Single-photon emission computed tomography (SPECT) imaging is used to accurately measure dopamine levels.
Purpose of the Study:
- To propose a novel Convolutional Neural Network (CNN), named JAN Net, specifically designed for Parkinson's disease identification.
- To utilize Volume Rendering Image Slices (VRIS) from SPECT scans for enhanced PD detection.
Main Methods:
- The JAN Net employs a modified exigent feature (M-ExFeat) block with convolutional and additive layers to preserve striatal features.
- Different-sized convolutional layers (1x1, 3x3, 5x5) extract multi-level features, which are combined in an additive layer to improve neuron learnability.
- Network performance was evaluated using stride 1 and stride 2 configurations.
Main Results:
- The JAN Net achieved 100% training and validation accuracy with minimal loss for stride 2, using data from the Parkinson's Progression Markers Initiative (PPMI) database.
- The proposed architecture demonstrated superior performance compared to various deep learning models and machine learning techniques, including Extreme Learning Machines (ELM) and Artificial Neural Networks (ANN).
Conclusions:
- The developed JAN Net shows significant efficacy in identifying Parkinson's disease.
- This research offers a valuable tool for neurologists to potentially prevent neuronal impairment in PD patients.
Related Concept Videos
Parkinson's Disease: Overview
612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Treatment
305
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
305


